Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedAug 23, 2017Caffeine PowderMarketed without an Approved NDA/ANDA: The product consists of pure, powdered caffeine and is an unapproved drug due to stimulant claims. The product is also misbranded...Global Marketing Enterprises, Inc. · D-1096-2017Class IITerminatedAug 23, 2017Entecavir Tablets 0.5 mgFailed Impurities/Degradation Specification: single unknown impurity OOS 0.33% (Limit:NMT 0.20%W/W) at the three month stability point.Hetero USA Inc · D-1095-2017Class IIITerminatedAug 23, 2017Voriconazole TabletsFailed impurities/degradation specifications: Out of specification for a related compound C.AVKARE Inc. · D-1094-2017Class ITerminatedAug 23, 2017Mibelas 24 FeContraceptive Tablets Out of Sequence- First 4 pills of the packet are brown, instead of the last four pills and the expiry/lot was not printed on the package.Lupin Limited (Unit 1) · D-1093-2017Class ITerminatedAug 23, 2017GEC LX Laxoplex 60 capsules Dietary SupplementMarketed Without An Approved NDA/ANDA: Tainted Product Marketed As a Dietary Supplement: FDA analysis found the product to tainted with undeclared anabolic steroids and...Genetic Edge Compounds LLC · D-1092-2017Class IITerminatedAug 23, 20170.9% Sodium Chloride InjectionPresence of Particulate Matter; stainless steelICU Medical Inc · D-1091-2017Class IIITerminatedAug 23, 2017Halyard 24-Hour Oral Care Kit q4Crystallization with subpotent out of specification assay results for chlorhexidine.Akorn Inc · D-1090-2017Class IIITerminatedAug 23, 2017Halyard 24-Hour Oral Care Kit q2Crystallization with subpotent out of specification assay results for chlorhexidine.Akorn Inc · D-1089-2017Class IIITerminatedAug 23, 2017Chlorhexidine Gluconate Oral RinseCrystallization with subpotent out of specification assay results for chlorhexidine.Akorn Inc · D-1088-2017Class ITerminatedAug 23, 2017Biotech Underground Tri-Ton Hardcore Formula capsulesMarketed Without An Approved NDA/ANDA: Tainted Product Marketed As a Dietary Supplement: Product was tested by FDA and found to contain andarine and ostarine.Dynamic Technical Formulations · D-1087-2017Class IITerminatedAug 23, 2017Procrit Epoetin Alfa 40Presence of particulate matter: Visible glass flakes identified as lamellae in some drug product vials.Amgen, Inc. · D-1086-2017Class ITerminatedAug 23, 2017D-ZINE Rapid Size and Strength capsulesMarketed Without An Approved NDA/ANDA: Product contains Methylstenbolone or Dymethazine.Hardcore Formulations · D-1085-2017Class ITerminatedAug 23, 2017ULTRA-STEN Rapid Size and Strength capsulesMarketed Without An Approved NDA/ANDA: Product contains Methylstenbolone or Dymethazine.Hardcore Formulations · D-1084-2017Class IIITerminatedAug 23, 2017Phentermine HCL CapsulesFailed Impurities/Degradation Specifications: out-of-specification results obtained for individual unknown impurities found at 30 month Room Temperature Retained Sample...KVK-Tech, Inc. · D-1083-2017Class IITerminatedAug 16, 2017Hydromorphone Hydrochloride InjectionPresence of Particulate Matter: Silicone oilHospira Inc, Lake Forest · D-1082-2017Class IITerminatedAug 16, 2017Hydromorphone Hydrochloride InjectionPresence of Particulate Matter: Silicone oilHospira Inc, Lake Forest · D-1081-2017Class IITerminatedAug 16, 2017Hydromorphone Hydrochloride InjectionPresence of Particulate Matter: Silicone oilHospira Inc, Lake Forest · D-1080-2017Class IITerminatedAug 16, 2017Rocuronium Bromide Injection Solution 5 mLLack of Sterility Assurance.Cantrell Drug Company · D-1079-2017Class IITerminatedAug 16, 2017Neostigmine Methylsulfate Injection Solution 5 mLLack of Sterility Assurance.Cantrell Drug Company · D-1078-2017Class IITerminatedAug 16, 2017Adenosine in 0.9% Sodium Chloride 30mLLack of Sterility Assurance.Cantrell Drug Company · D-1076-2017Class IITerminatedAug 16, 2017Sodium Bicarbonate 8.4% Injection Solution 50 mLLack of Sterility Assurance.Cantrell Drug Company · D-1075-2017Class IITerminatedAug 16, 2017Phenylephrine HCL in 0.9% Sodium Chloride 10 mLLack of Sterility Assurance.Cantrell Drug Company · D-1074-2017Class IITerminatedAug 16, 2017Diltiazem HCl 125 mg in 5% Dextrose 125 mL Single-Dose- BagLack of Sterility Assurance.Cantrell Drug Company · D-1073-2017Class IITerminatedAug 16, 2017Norepinephrine Bitartrate 4 mg Added to 0.9% Sodium Chloride 250 mLLack of Sterility Assurance.Cantrell Drug Company · D-1072-2017Class IITerminatedAug 16, 2017Norepinephrine Bitartrate 16 mg Added to 0.9% Sodium Chloride 250 mLLack of Sterility Assurance.Cantrell Drug Company · D-1071-2017Class IITerminatedAug 16, 2017Norepinephrine Bitartrate 8 mg Added to 0.9% Sodium Chloride 250 mLLack of Sterility Assurance.Cantrell Drug Company · D-1070-2017Class IITerminatedAug 16, 2017Succinylcholine Chloride Injection Solution 5 mLLack of Sterility Assurance.Cantrell Drug Company · D-1069-2017Class IITerminatedAug 16, 2017Succinylcholine Chloride Injection Solution 10 mLLack of Sterility Assurance.Cantrell Drug Company · D-1068-2017Class IITerminatedAug 16, 2017Glycopyrrolate Injection SolutionLack of Sterility Assurance.Cantrell Drug Company · D-1067-2017Class IITerminatedAug 16, 2017Glycopyrrolate Injection SolutionLack of Sterility Assurance.Cantrell Drug Company · D-1066-2017Class IITerminatedAug 16, 2017Glycopyrrolate Injection SolutionLack of Sterility Assurance.Cantrell Drug Company · D-1065-2017Class IITerminatedAug 16, 2017Ephedrine Sulfate in 0.9% Sodium Chloride 5 mLLack of Sterility Assurance.Cantrell Drug Company · D-1064-2017Class IITerminatedAug 16, 2017Ephedrine Sulfate Injection Solution 1 mLLack of Sterility Assurance.Cantrell Drug Company · D-1063-2017Class IITerminatedAug 16, 2017Ephedrine Sulfate in 0.9% Sodium Chloride 5 mLLack of Sterility Assurance.Cantrell Drug Company · D-1062-2017Class IITerminatedAug 16, 2017Ephedrine Sulfate in 0.9% Sodium Chloride 10 mLLack of Sterility Assurance.Cantrell Drug Company · D-1061-2017Class IITerminatedAug 16, 2017Oxygen Refrigerated Liquid USP UN 1073GMP Deviations: The firm does not include an SOP for testing for out of specifications.AtHome Medical, Inc. · D-1060-2017Class IITerminatedAug 16, 2017Nystatin Topical PowderPresence of Foreign Substance: potential presence of plastic particles.X-Gen Pharmaceuticals Inc. · D-1059-2017Class IIITerminatedAug 16, 2017Glipizide Extended-Release TabletsFailed Moisture Limits: out of specification test results for water content obtained during stability testing.Teva Pharmaceuticals USA · D-1058-2017Class IITerminatedAug 9, 2017Famotidine USP 20 mgFailed Tablet/Capsule Specification: out of specification for tablet weight.PD-Rx Pharmaceuticals, Inc. · D-1057-2017Class IITerminatedAug 9, 2017Famotidine Tablets USPFailed Tablet/Capsule Specification; out of specification for tablet weightTeva Pharmaceuticals USA · D-1056-2017